Effect of biotechnological cytochromec on the early postocclusion and reperfusion arrhythmias

Biotechnological cytochromec showed a lower antiarrhythmic activity in cats with acute occlusion and reperfusion arrhythmias than trimecaine, verapamil, and quaternidine but a higher activity than anapriline. Under experimental conditions, cytochromec potentiated the antiarrhythmic effect of trimeca...

Full description

Saved in:
Bibliographic Details
Published inBulletin of experimental biology and medicine Vol. 127; no. 1; pp. 80 - 82
Main Authors Balykova, L. A., Balashov, V. P., Kostin, Ya. V., Sernov, L. N.
Format Journal Article
LanguageEnglish
Published New York Springer Nature B.V 01.01.1999
Online AccessGet full text

Cover

More Information
Summary:Biotechnological cytochromec showed a lower antiarrhythmic activity in cats with acute occlusion and reperfusion arrhythmias than trimecaine, verapamil, and quaternidine but a higher activity than anapriline. Under experimental conditions, cytochromec potentiated the antiarrhythmic effect of trimecaine and quaternidine.[PUBLICATION ABSTRACT]
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0007-4888
1573-8221
DOI:10.1007/BF02432808